Evidence map›Paper›PMID 35008277›Full record

ArticleCancers2021

Orai2 Modulates Store-Operated Ca

Jose Sanchez-Collado, Jose J Lopez, Carlos Cantonero, Isaac Jardin, Sergio Regodón, Pedro C Redondo, Juan Gordillo, Tarik Smani, Gines M Salido, Juan A Rosado

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Physiological functions of calcium signaling via Orai1 in cancer.The journal of physiological sciences : JPS · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Science CommuniCaCells · 2022
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jose Sanchez-ColladoCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.
Jose J LopezCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.ORCID 0000-0002-5234-1478
Carlos CantoneroCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.
Isaac JardinCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.ORCID 0000-0003-4575-8264
Sergio RegodónCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.
Pedro C RedondoCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.ORCID 0000-0002-2067-2627
Juan GordilloPathology Service, Hospital de Merida, 06800 Merida, Spain.
Tarik SmaniDepartment of Medical Physiology and Biophysics, University of Seville, 41004 Seville, Spain.ORCID 0000-0002-1877-7438
Gines M SalidoCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.ORCID 0000-0002-8687-2445
Juan A RosadoCellular Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers (IMPB), University of Extremadura, 10003 Caceres, Spain.ORCID 0000-0002-9749-2325
Universidad de Extremadura · ESInstituto de Arqueología-Mérida · ESInstituto de Biomedicina de Sevilla · ES

Funding

Consejería de Educación y Empleo, Junta de Extremadura GR18061Consejería de Educación y Empleo, Junta de Extremadura GR21008Consejería de Educación y Empleo, Junta de Extremadura IB20007Consejería de Educación y Empleo, Junta de Extremadura PD16072Ministerio de Ciencia e Innovación PID2019-104084GB-C21Ministerio de Ciencia e Innovación PID2019-104084GB-C22
6 · The paper itself

Abstract

Breast cancer is a heterogeneous disease from the histological and molecular expression point of view, and this heterogeneity determines cancer aggressiveness. Store-operated Ca

Indexed as

breast cancercell cycleNFATOrai2store-operated calcium entry

Identifiers

PMID35008277
PMCPMC8749845
OpenAlexW4200254000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.